Literature DB >> 1535905

Osteosarcoma: chemotherapy-induced changes at MR imaging.

H C Holscher1, J L Bloem, D Vanel, J Hermans, M A Nooy, A H Taminiau, M Henry-Amar.   

Abstract

Fifty-seven patients undergoing chemotherapy for osteosarcoma underwent evaluation with magnetic resonance (MR) imaging to identify changes related to a good or poor response. Spin-echo MR images obtained after preoperative chemotherapy were compared with images obtained before treatment. Histopathologic examination of each resected specimen was used to quantify the response. An increase in tumor volume and increased or unchanged edema were predictive of a poor histopathologic response (predictive values, 85%-92%). Decreased or unchanged tumor volume and a decrease in edema were poor predictors of a good response (predictive values, 56%-62%). Improved tumor demarcation, an increase in the size of areas of low signal intensity, and a decrease in joint effusion occurred independently of histopathologic response in almost half of the patients. With a subjective interpretation of MR images, poor respondents can be identified if an increase in tumor volume or no decrease in the amount of edema is seen. Subjective criteria do not contribute to the identification of good respondents.

Entities:  

Mesh:

Year:  1992        PMID: 1535905     DOI: 10.1148/radiology.182.3.1535905

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  25 in total

1.  Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Authors:  Timm Denecke; Patrick Hundsdörfer; Daniel Misch; Ingo G Steffen; Stefan Schönberger; Christian Furth; Michail Plotkin; Juri Ruf; Hubertus Hautzel; Brigitte Stöver; Regine Kluge; Uta Bierbach; Sylke Otto; James F Beck; Christiane Franzius; Günter Henze; Holger Amthauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

2.  Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma.

Authors:  Chang-Bae Kong; Won Seok Song; Wan Hyeong Cho; Jung Moon Oh; Dae-Geun Jeon
Journal:  Clin Orthop Relat Res       Date:  2011-10-19       Impact factor: 4.176

3.  Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results.

Authors:  C Baunin; G Schmidt; K Baumstarck; C Bouvier; J C Gentet; A Aschero; A Ruocco; B Bourlière; G Gorincour; C Desvignes; N Colavolpe; G Bollini; P Auqier; P Petit
Journal:  Skeletal Radiol       Date:  2012-02-09       Impact factor: 2.199

Review 4.  Imaging pediatric bone sarcomas.

Authors:  Sue C Kaste
Journal:  Radiol Clin North Am       Date:  2011-06-16       Impact factor: 2.303

5.  Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI.

Authors:  Byung Hyun Byun; Chang-Bae Kong; Ilhan Lim; Byung Il Kim; Chang Woon Choi; Won Seok Song; Wan Hyeong Cho; Dae-Geun Jeon; Jae-Soo Koh; Soo-Yong Lee; Sang Moo Lim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-21       Impact factor: 9.236

6.  Ultrasonographic monitoring of the effects of preoperative chemotherapy in osteosarcoma and Ewing's sarcoma.

Authors:  T Kinoshita; S Tatezaki; O Matsuzoki; M Inoue
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

7.  Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.

Authors:  Dae-Geun Jeon; Won Seok Song; Wan Hyeong Cho; Chang-Bae Kong; Sang Hyun Cho
Journal:  Clin Orthop Relat Res       Date:  2014-02-27       Impact factor: 4.176

Review 8.  Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.

Authors:  Hervé Brisse; Liliane Ollivier; Véronique Edeline; Hélène Pacquement; Jean Michon; Christophe Glorion; Sylvia Neuenschwander
Journal:  Pediatr Radiol       Date:  2004-04-22

9.  The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.

Authors:  Kiyoshi Oka; Toshitake Yakushiji; Hiro Sato; Toshinori Hirai; Yasuyuki Yamashita; Hiroshi Mizuta
Journal:  Skeletal Radiol       Date:  2009-11-19       Impact factor: 2.199

10.  MR imaging of edema accompanying benign and malignant bone tumors.

Authors:  H M Kroon; J L Bloem; H C Holscher; H J van der Woude; M Reijnierse; A H Taminiau
Journal:  Skeletal Radiol       Date:  1994-05       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.